Rarity Bioscience wins prestigious Disruptive Technology Award
Rarity Bioscience has received the prestigious Disruptive Technology Award for its proprietary technology, superRCA™, which enables exceptionally sensitive detection of DNA mutations in common samples. The technology can detect a single mutation among 100,000 normal molecules – a capability that is critical for patients with cancer and other mutation-driven diseases, where early diagnosis, treatment monitoring, […]